Suprava TZ 562.5 mg Injection 1's

Suprava TZ 562.5 mg Injection 1's belongs to a class of medication called 'antibiotics' used to treat several bacterial infections of the urinary tract, blood, bones and joints, heart, brain, chest, ears, skin, or soft tissues. A bacterial infection is a condition in which harmful bacteria grow in the body and cause infection. It can infect any part of the body and multiply very quickly. Suprava TZ 562.5 mg Injection 1's does not work against infections caused by the virus.

Suprava TZ 562.5 mg Injection 1's is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor). Ceftriaxone belongs to the class of antibiotics that works by interfering with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damaging the bacterial cell wall and killing bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.

You are advised to take Suprava TZ 562.5 mg Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience diarrhea, rash, or abnormalities with white blood cells and platelets. Most of these side effects of Suprava TZ 562.5 mg Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Suprava TZ 562.5 mg Injection 1's, penicillins, or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. Drive only if you are alert as Suprava TZ 562.5 mg Injection 1's may cause dizziness. You are recommended to complete the full course of Suprava TZ 562.5 mg Injection 1's as prescribed by your doctor for effective results. Suprava TZ 562.5 mg Injection 1's may interact with certain tests such as glucose (sugar) in urine and coomb’s test, giving unusual results. Therefore, inform the doctor that you are taking Suprava TZ 562.5 mg Injection 1's before undergoing any tests.

Suprava TZ 562.5 mg Injection 1's is used in the treatment of bacterial infections. The detailed uses of Suprava TZ 562.5 mg Injection 1's are as follows:

• Treatment of Bacterial Infections: Suprava TZ 562.5 mg Injection 1's is commonly prescribed to manage bacterial infections, including those targeting the respiratory tract, urinary tract, and skin, ensuring effective treatment.
• Post-Surgical Infection Prevention: Suprava TZ 562.5 mg Injection 1's may be administered to reduce the risk of infections in patients undergoing surgery, particularly during high-risk procedures.
• Management of Sepsis: Suprava TZ 562.5 mg Injection 1's is used as part of the treatment regimen for sepsis, a life-threatening condition caused by infection.
• Pneumonia Treatment: Suprava TZ 562.5 mg Injection 1's is effective in treating pneumonia, especially when caused by bacterial pathogens sensitive to its active components.
• Typhoid Fever Management: Suprava TZ 562.5 mg Injection 1's may be prescribed for typhoid fever, particularly in situations where oral medications are unsuitable or ineffective.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Suprava TZ 562.5 mg Injection 1's will be administered by the doctor or nurse in a healthcare setting.
• Do not self-administer.

Suprava TZ 562.5 mg Injection 1's is a combination of two drugs: Ceftriaxone (antibiotic) and Tazobactum (beta-lactamase inhibitor) used to treat several bacterial infections. Ceftriaxone is a broad-spectrum antibiotic that acts against both aerobic (grow in the presence of oxygen) and anaerobic (grow in the absence of oxygen) gram-negative and gram-positive bacteria. It interferes with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance. 

If you are allergic to Suprava TZ 562.5 mg Injection 1's, penicillins, or any other medicines, please tell your doctor. If you have kidney or liver problems, diarrhea, hemolytic anemia (reduction in red blood cells that may make your skin pale yellow and cause breathlessness or weakness), kidney or gall stones, or inflammation of the large intestine, inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. If you are pregnant or breastfeeding, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's. Drive only if you are alert as Suprava TZ 562.5 mg Injection 1's may cause dizziness. You are recommended to complete the full course of Suprava TZ 562.5 mg Injection 1's as prescribed by your doctor for effective results. Suprava TZ 562.5 mg Injection 1's may interact with certain tests such as glucose (sugar) in urine and coomb’s test, giving unusual results. Therefore, inform the doctor that you are taking Suprava TZ 562.5 mg Injection 1's before undergoing any tests. If you are on a low-sodium diet or are about to receive calcium-containing products, please inform your doctor before taking Suprava TZ 562.5 mg Injection 1's.